SEO URLwww.firestrike.ai/deals/ajax-therapeutics-lilly-acquisition-2026-1
acquisitionAnnounced · Apr 27, 2026PharmaceuticalsSource · CredibleArticle · Factual
Lilly acquires Ajax Therapeutics
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$2.3B
Target
Ajax Therapeutics
New York City, New York
Acquirer
Lilly
Full Acquisition
Status
Announced
Lilly agreed to acquire Ajax Therapeutics. Reported deal value: $2.3B. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: New York City, New York, United States.
This page summarizes publicly available information about the transaction as of 2026-04-27. Figures and status may change as filings and press coverage update.
Eli Lilly has added yet another string to its M&A bow of 2026 after agreeing to acquire cancer specialist Ajax Therapeutics in a deal worth up to $2. 3bn
Deal timeline
Announced
Apr 27, 2026 · pharmaceutical-technology.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $2.3B. Figures and status may change as sources update.
Sources: pharmaceutical-technology.com · Primary article · FireStrike proprietary index